Y
Ying Huang
Researcher at Sun Yat-sen University
Publications - 115
Citations - 2596
Ying Huang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 24, co-authored 83 publications receiving 1923 citations. Previous affiliations of Ying Huang include Jinan University & Wuhan University.
Papers
More filters
Journal ArticleDOI
Mesoporous silica nanoparticles for drug and gene delivery.
Yixian Zhou,Guilan Quan,Qiaoli Wu,Xiaoxu Zhang,Boyi Niu,Biyuan Wu,Ying Huang,Xin Pan,Chuanbin Wu +8 more
TL;DR: The exciting progress in the development of MSNs-based effective delivery systems for poorly soluble drugs, anticancer agents, and therapeutic genes are highlighted.
Journal ArticleDOI
Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.
Zhi Ming Li,Jia Jia Huang,Yi Xia,Jian Sun,Ying Huang,Yu Wang,Ying Jie Zhu,Ya Jun Li,Wei Zhao,Wen Xiao Wei,Tong Yu Lin,Hui Qiang Huang,Wen Qi Jiang +12 more
TL;DR: Baseline LMR, a surrogate biomarker of the immune microenvironment, is an effective prognostic factor in DLBCL patients treated with R-CHOP therapy and could also identify high-risk patients in the low-risk IPI category.
Journal ArticleDOI
Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.
Fei Han,Chong Zhao,Shao Min Huang,Li Xia Lu,Ying Huang,Xiao Wu Deng,Wei Yuan Mai,Bin S. Teh,E. Brian Butler,Tai Xiang Lu +9 more
TL;DR: Re-irradiation using IMRT is available to improve local tumour control and to prolong patients' survival and a smaller tumour volume, higher fractional dose, younger patient ages, lower rN(0) stage and early recurrent stage are all independent prognostic factors for overall survival of recurrent NPC.
Journal ArticleDOI
A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, Tangential-IMRT, Multi-beam IMRT and VMAT
TL;DR: Compared to other techniques, the T-IMRT technology reduced radiation dose exposure to normal tissues and maintained reasonable target homogeneity, VMAT is not recommended for left-sided breast cancer treatment.
Journal ArticleDOI
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lin Quan Tang,Dong Ping Chen,Ling Guo,Hao Yuan Mo,Ying Huang,Shan Shan Guo,Bin Qi,Qing Nan Tang,Pan Wang,Xiao Yun Li,Jibin Li,Qing Liu,Yuanhong Gao,Fang Yun Xie,Li Ting Liu,Yang Li,Sai Lan Liu,Hao Jun Xie,Yu Jing Liang,Xue Song Sun,Jin Jie Yan,Yi Shan Wu,Dong Hua Luo,Pei Yu Huang,Yan Qun Xiang,Rui Sun,Ming-Yuan Chen,Xing Lv,Lin Wang,Wei Xiong Xia,Chong Zhao,Ka Jia Cao,Chao-Nan Qian,Xiang Guo,Ming-Huang Hong,Zhi Qiang Nie,Qiu Yan Chen,Hai-Qiang Mai +37 more
TL;DR: This trial assessed whether a nedaplatin-based concurrent chemoradiotherapy regimen was non-inferior to a cisplatin -based regimen in patients with locoregional, stage II-IVB nasopharyngeal carcinoma in China.